WV DHHR to receive $1.9 million in Mylan EpiPen settlement

By  | 

CHARLESTON, WV - The West Virginia Department of Health and Human Resources (DHHR) Medicaid Fraud Control Unit announced it will receive more than $1.9 million in restitution and other recovery from a previously reported settlement agreement between the State of West Virginia and Mylan Pharmaceuticals, Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.

The final settlement resolved allegations that Mylan Pharmaceuticals made false statements to Medicaid by misclassifying its EpiPen product and lowered the amount of rebates the company was required to pay to Medicaid under federal law.

According to the Medicaid Fraud Control Unit, all 50 U.S. states have entered into settlement agreements with Mylan.

The National Association of Medicaid Fraud Control Units put together a team of member states who participated in the settlement negotiations with Mylan, and included research and data from DHHR’s Medicaid Fraud Control Unit.

"West Virginia’s Medicaid Fraud Control Unit worked diligently with the national team to resolve this case. We are pleased to have secured the return of these funds to the Medicaid program," said Kathy Lawson, DHHR Inspector General.

To report Medicaid provider fraud or patient abuse, neglect or financial exploitation, call 1-304-558-1858, or toll-free at 1-888-FRAUD-WV (1-888-372-8398).



 
Comments are posted from viewers like you and do not always reflect the views of this station. powered by Disqus